Japan Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Japan Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Japan Clinical Nutrition for Diabetes Care Market was valued at $133.64 Mn in 2023 and is predicted to grow at a CAGR of 5.28% from 2023 to 2030, to $191.58 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.

ID: IN10JPPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Avantika Gupta

Buy Now

Japan Clinical Nutrition for Diabetes Care Market Executive Summary

The Japan Clinical Nutrition for Diabetes Care Market is at around $133.64 Mn in 2023 and is projected to reach $191.58 Mn in 2030, exhibiting a CAGR of 5.28% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Otsuka Pharmaceutical Co. Ltd, Nestlé Japan is known for its extensive portfolio of medications, including those essential for diabetes care. Eisai Co. Ltd, Roche Holdings AG, and Sanofi are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Japan Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: Japan is experiencing a significant rise in its diabetes population, with the country facing a growing epidemic of both type 1 and type 2 diabetes. According to the International Diabetes Federation, about 11.8% of the total adult population is living with diabetes. Rapid urbanization, sedentary lifestyles, unhealthy dietary habits, and genetic predispositions are among the key drivers of the diabetes epidemic in Japan.

Innovation in Products and Services: Companies are developing new and improved clinical nutrition products specifically catering to Japanese preferences and dietary needs. These may include sugar-controlled snack options, culturally appropriate enteral formulas, and personalized mobile applications for dietary tracking. Innovation in both products and service delivery methods can attract patients and healthcare providers to embrace clinical nutrition as part of a comprehensive diabetes management plan.

Increasing Awareness and Adoption: There is a growing recognition of the importance of implementing effective strategies to address the challenges posed by the high incidence of diabetes in Japan, including the effective nutritional management of patients suffering from the disease. This framework aims to provide a unified policy direction to improve access to prevention, treatment, and support services for all Canadians with diabetes. Organizations like the Japan Society of Nutrition and Food Science (JSNFS) are working to create awareness about clinical nutrition and promote its adoption for public health.

Market Restraints

High Cost of Specialised Products: Specialized diabetic food products and enteral formulas can be significantly more expensive than regular groceries. This can be a burden for low-income individuals and families, limiting access to optimal clinical nutrition support.

Stringent Regulations: Japan has strict labeling regulations for food products, including those marketed for diabetic diets. This can make it challenging for companies to introduce new and innovative products to the market.

Cultural Preferences and Misconceptions: Traditional Japanese dietary patterns often emphasize rice and noodles, which can be challenging for diabetic management. Additionally, misconceptions about "diabetic" labeled foods and the role of clinical nutrition in diabetes management can hinder patient adoption.

Regulatory Landscape and Reimbursement Scenario

In Japan, the market for clinical nutrition products is supervised and regulated by the Ministry of Health, Labour, and Welfare (MHLW). Clinical nutrition products for diabetes care in Japan are subject to the Pharmaceutical Affairs Law and other relevant regulations. Products must have clear and accurate labeling, including information on ingredients, nutritional content, intended use, and any potential risks or interactions with medications. The Japan Diabetes Society (JDS) publishes evidence-based guidelines for diabetes management, including nutritional recommendations.

Japan operates a universal health insurance system (National Health Insurance System) where all citizens are required to enroll. This system covers most medical services, including nutritional counseling for diabetes care. Outpatient nutritional counseling sessions provided by Registered Dietitians (RDs) are reimbursable under the national health insurance system.

Competitive Landscape

Key Players

Here are some of the major key players in the Japan Clinical Nutrition for Diabetes Care Market:

Abbott Japan
Eisai Co. Ltd
Otsuka Pharmaceutical Co. Ltd
Nestlé Japan
Dexcom
Eli Lily
Sanofi
Ascensia Diabetes Care
Roche Holdings AG
Arkay Inc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Japan Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.